methotrexate has been researched along with Obesity in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (13.56) | 18.7374 |
1990's | 7 (11.86) | 18.2507 |
2000's | 9 (15.25) | 29.6817 |
2010's | 28 (47.46) | 24.3611 |
2020's | 7 (11.86) | 2.80 |
Authors | Studies |
---|---|
Arias-de la Rosa, I; Barbarroja, N; Collantes-Estévez, E; Cordoba, J; Cuesta-López, L; Escudero-Contreras, A; Gahete, MD; González, A; Leiva-Cepas, F; López-Pedrera, C; Lucendo, AJ; Navarro, P; Ortega, R; Pérez-Pampin, E; Pérez-Sánchez, C; Ruiz-Ponce, M | 1 |
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ | 1 |
Debacker, KC; Derstine, B; Pai, MP; Su, GL; Sullivan, J; Wang, SC | 1 |
Arlegui, H; Assan, F; Bachelez, H; Beneton, N; Beylot-Barry, M; Chosidow, O; Dupuy, A; Giboin, C; Joly, P; Jullien, D; Mahé, E; Paul, C; Richard, MA; Sbidian, E; Tubach, F; Viguier, M | 1 |
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
Bergstra, SA; Dey, M; Goodson, NJ; Landewe, RB; Moots, RJ; Zhao, SS | 1 |
Eaton, P; Rudyk, O | 1 |
Alazawi, W; Cho, W; Shetty, A; Syn, WK | 1 |
Bonifati, C; Graceffa, D; Lora, V | 1 |
Kaeley, GS; Kalabic, J; MacCarter, DK; Pangan, AL; Ranganath, VK; Wang, X | 1 |
Chiricozzi, A; Girolomoni, G; Gisondi, P | 1 |
Baran, A; Flisiak, I; Kiluk, P; Maciaszek, M; Świderska, M | 1 |
Di Minno, MN; Iervolino, S; Lupoli, R; Peluso, R; Russolillo, A; Scarpa, R | 1 |
Calhau, C; Cunha, A; Faria, A; Keating, E; Marques, C; Meireles, M; Monteiro, R; Pestana, D; Teixeira, D | 1 |
Pais, R; Ratziu, V; Rusu, E | 1 |
Gerdes, S; Mrowietz, U; Steinz, K | 1 |
Alfredsson, L; Bengtsson, C; Källberg, H; Klareskog, L; Saevarsdottir, S; Sandberg, ME; Wesley, A | 1 |
Kirby, B; Ryan, C | 1 |
Lopez-Ferrer, A; Puig, L; Spertino, J; Vilarrasa, E | 1 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA | 1 |
Philipsen, P; Skiveren, J; Therming, G | 1 |
Prussick, R; Unnebrink, K; Valdecantos, WC | 1 |
Avsar, E; Ergun, T; Ozgen, Z; Seckin, D; Tula, E | 1 |
Amadori, D; Antonucci, G; Biglia, N; Bruzzi, P; Farolfi, A; Gennari, A; Gianni, L; Maltoni, R; Mangia, A; Nanni, O; Paradiso, A; Rocca, A; Scarpi, E; Tienghi, A | 1 |
Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
Francès, C | 1 |
Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS | 1 |
Dann, F; Gottlieb, AB | 1 |
Bulai Livideanu, C; Lahfa, M; Mazereeuw-Hautier, J; Paul, C | 1 |
Aronow, BJ; Gibson, G; Kim, J; Mason, E; Matigian, N; Nones, K; Tronc, G; Wells, C; Wolfinger, RD | 1 |
Ferrazzi, A; Girolomoni, G; Gisondi, P | 1 |
Balwierz, W; Bik-Multanowski, M; Galicka-Latala, D; Gozdzik, J; Pietrzyk, JJ; Strojny, W; Surmiak, M; Szymon, S | 1 |
Del Giglio, M; Girolomoni, G; Gisondi, P; Tessari, G | 1 |
Acedo, SC; Carvalho, Pde O; DeOliveira, CC; Gambero, A; Gotardo, EM; Pedrazzoli, J; Rocha, T | 1 |
Menter, A; Ryan, C | 1 |
Abritta, G; Cravero, A; Enriquez, N; Martínez Artola, Y; Ortiz, V; Palermo, C; Poncino, D; Rosenberg, S; Santiago García, D; Saturansky, E | 1 |
Forien, M; Mahé, E; Marchal, A; Sigal, ML; Sin, C | 1 |
Barthelemy, H; Beauchet, A; Begon, E; Boyé, T; Bravard, P; Chaby, G; Descamps, V; Estève, E; Girard, C; Maccari, F; Mahé, E; Maillard, H; Quiles-Tsimaratos, N; Reguiai, Z; Schmutz, JL; Sigal, ML | 1 |
Hongeng, S; Hudson, MM; Pui, CH; Razzouk, BI; Rose, SR; Smeltzer, MP; Wallace, D; Zacher, M | 1 |
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS | 1 |
Chabrun, E; Chanteloup, E; Couzigou, P; de Lédinghen, V; Laharie, D; Terrebonne, E; Vergniol, J | 1 |
Hicke, A; Sońta-Jakimczyk, D; Tomaszewska, R; Wieczorek, M | 1 |
Colwell, SJ; Eastwood, BJ; Malatjalian, DA; Ross, JB; Williams, CN | 1 |
Bernáldez-Ríos, R; Espinoza-Hernández, L; Fajardo-Gutíerrez, A; Martínez-García, MC; Mejía-Arangure, JM; Rodríguez-Zepeda, MC | 1 |
Donaldson, M; Gibson, B; Ralston, JM; Reilly, JJ; Ventham, JC | 1 |
Blomqvist, C; Joensuu, H; Poikonen, P | 1 |
Bjarnason, GA; Franssen, E; Madarnas, Y; Sawka, CA | 1 |
Lewis, V; Piatkowski, J; Rydholm, N; Sauer, M; Steiner, M | 1 |
Russo, A; Schilirò, G; Sciotto, A; Vigo, R | 1 |
Nyfors, A; Poulsen, H | 2 |
Beattie, CW; Das Gupta, TK; Mehta, RR | 1 |
Cera, PJ; Mangan, TF; Newman, ED; Phillips, CA | 1 |
Eldridge, RM; Fleming, RA; Johnson, CE; Stewart, CF | 1 |
Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC | 1 |
Akerman, M; Berge, G; Lundquist, A; Rorsman, H | 1 |
Bergfeld, WF; Hawk, WA; Owens, FJ; Roenigk, HH; St Jacques, R | 1 |
Carnelli, V; Masera, G | 1 |
9 review(s) available for methotrexate and Obesity
Article | Year |
---|---|
Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
Topics: Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Dermatologic Agents; Diabetes Mellitus; Humans; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors | 2017 |
The pharmacological management of patients with comorbid psoriasis and obesity.
Topics: Adipokines; Antibodies, Monoclonal; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Methotrexate; Obesity; Phototherapy; Psoriasis | 2019 |
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
Topics: Acetaminophen; Anesthetics; Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Insulin Resistance; Male; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Risk Factors; Trans-Activators; Viral Regulatory and Accessory Proteins | 2014 |
Psoriasis: to treat or to manage?
Topics: Antibodies, Anti-Idiotypic; Biological Products; Comorbidity; Humans; Immunosuppressive Agents; Methotrexate; Obesity; Psoriasis; Risk Factors; Treatment Outcome | 2014 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Comorbidities in patients with psoriasis.
Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Dermatologic Agents; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Methotrexate; Neoplasms; Obesity; Psoriasis | 2009 |
Metabolic comorbidities and psoriasis.
Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Insulin Resistance; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Psoriasis; Risk Factors | 2010 |
Psoriasis and cardiovascular disorders.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cardiotonic Agents; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Humans; Inflammation; Interleukin-12 Subunit p40; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2012 |
[The liver and methotrexate].
Topics: Alcohol Drinking; Diabetes Complications; Drug Monitoring; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Methotrexate; Obesity; Risk Factors | 2008 |
6 trial(s) available for methotrexate and Obesity
Article | Year |
---|---|
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.
Topics: Adalimumab; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Obesity; Synovial Membrane; Treatment Outcome | 2018 |
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Caloric Restriction; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Overweight; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Dermatologic Agents; Female; Humans; Ideal Body Weight; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2015 |
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Obesity; Prognosis; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study.
Topics: Adult; Aged; Body Mass Index; Dermatologic Agents; Diet, Reducing; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Loss | 2012 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen | 1985 |
44 other study(ies) available for methotrexate and Obesity
Article | Year |
---|---|
Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Cross-Sectional Studies; Humans; Inflammation; Liver Diseases; Longitudinal Studies; Methotrexate; Mice; Obesity; Peptides, Cyclic | 2023 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids | 2020 |
Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High-Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Size; Central Nervous System Neoplasms; Female; Humans; Kidney; Lymphoma; Male; Medical Records; Methotrexate; Middle Aged; Obesity; Retrospective Studies | 2020 |
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Biological Therapy; Body Mass Index; Cohort Studies; Dermatologic Agents; Etanercept; Female; France; Humans; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Patient Selection; Psoriasis; Ustekinumab | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR database.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Databases as Topic; Female; Humans; Linear Models; Logistic Models; Male; Methotrexate; Middle Aged; Obesity; Patient Acuity; Treatment Outcome | 2022 |
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
Topics: Animals; Aorta; Carmustine; Cattle; Cyclic GMP-Dependent Protein Kinase Type I; Diet, High-Fat; Endothelial Cells; Gene Expression Regulation; Glucagon; Hypertension; Leptin; Methotrexate; Mice; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resistin; Signal Transduction; Sugar Acids; Uncoupling Agents | 2017 |
Doubling golimumab doses did not improve skin disease in two obese patients with psoriatic arthritis.
Topics: Adult; Antibodies, Monoclonal; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Drug Substitution; Humans; Male; Methotrexate; Middle Aged; Obesity; Treatment Failure; Ustekinumab | 2017 |
Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acitretin; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Risk Factors; Young Adult | 2020 |
Methotrexate enhances 3T3-L1 adipocytes hypertrophy.
Topics: 3T3 Cells; Adipocytes; Adipogenesis; Animals; Arthritis, Rheumatoid; Biological Transport; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Folic Acid Antagonists; Glucose; Insulin; Lipid Metabolism; Metabolic Syndrome; Methotrexate; Mice; Obesity | 2013 |
Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Early Diagnosis; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Obesity; Overweight; Pain; Pain Measurement; Prognosis; Registries; Remission Induction; Severity of Illness Index; Sweden; Treatment Outcome | 2014 |
Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Cohort Studies; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Infusion Pumps; Kaplan-Meier Estimate; Longitudinal Studies; Male; Methotrexate; Middle Aged; Models, Statistical; Obesity; Psoriasis; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2014 |
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult | 2015 |
Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Atherosclerosis; Depressive Disorder; Diabetes Mellitus; Female; Health Knowledge, Attitudes, Practice; Humans; Hypertension; Immunosuppressive Agents; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Obesity; Patient Education as Topic; Psoriasis; Risk Factors; Thrombosis; Young Adult | 2015 |
Psoriasis and the liver: problems, causes and course.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Child; Dermatologic Agents; Diabetes Complications; Female; Humans; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Young Adult | 2017 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
[What's new in internal medicine?].
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteriophages; Body Mass Index; Diabetes Complications; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypereosinophilic Syndrome; Hypertension; Immunosuppressive Agents; Internal Medicine; Methotrexate; Mimiviridae; Obesity; Risk Factors; Treatment Outcome; Venous Thromboembolism | 2008 |
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Daunorubicin; Ethnicity; Female; Gastrointestinal Diseases; Glucose Intolerance; Humans; Incidence; Male; Methotrexate; Obesity; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Vincristine; Weight Gain; Weight Loss; Young Adult | 2009 |
Efficacy of ustekinumab in palmoplantar psoriasis.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Female; Humans; Male; Methotrexate; Obesity; Psoriasis; Smoking; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab; Vitamin D | 2010 |
Maternal influences on the transmission of leukocyte gene expression profiles in population samples from Brisbane, Australia.
Topics: Australia; Body Mass Index; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes, Gestational; False Positive Reactions; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Leukocytes; Maternal Exposure; Methotrexate; Obesity; Pregnancy; Pregnancy Complications; Vitamin E | 2010 |
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Genetic Association Studies; Homozygote; Humans; Male; Methotrexate; Obesity; Odds Ratio; Overweight; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proteins; Radiotherapy; Risk Factors; Survivors; Thioguanine; Vincristine; Young Adult | 2011 |
Effects of methotrexate on inflammatory alterations induced by obesity: an in vivo and in vitro study.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Adiposity; Animals; Body Weight; Coculture Techniques; Cytokines; Diet, High-Fat; Epididymis; Inflammation; JNK Mitogen-Activated Protein Kinases; Lipolysis; Macrophages; Male; Methotrexate; Mice; Nitric Oxide Synthase Type II; Obesity; Phosphorylation | 2012 |
[Liver diseases in rheumatoid and psoriatic arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cross-Sectional Studies; Fatty Liver; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Risk Factors | 2012 |
[Body-weight changes in psoriatic patients on systemic treatment].
Topics: Adult; Aged; Antibodies, Monoclonal; Arthritis, Psoriatic; Body Weight; Comorbidity; Dermatologic Agents; Female; Humans; Infliximab; Long-Term Care; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Tumor Necrosis Factor-alpha | 2012 |
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Diet; Dyslipidemias; Female; Humans; Hypertension; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Weight Gain | 2014 |
Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2007 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha | 2008 |
[Obesity as the first manifestation of central nervous system involvement in acute lymphoblastic leukemia].
Topics: Antineoplastic Agents; Body Mass Index; Child; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Recurrence | 1996 |
Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Biopsy; Child; Diabetes Complications; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Liver; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Nova Scotia; Obesity; Psoriasis; Retrospective Studies; Risk Factors; Time Factors | 1996 |
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body Constitution; Child; Child, Preschool; Cohort Studies; Cytarabine; Drug Administration Schedule; Energy Metabolism; Epirubicin; Female; Gastrointestinal Diseases; Hospitals, General; Hospitals, Pediatric; Humans; Infant; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Nutritional Status; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Skinfold Thickness; Vincristine | 1997 |
Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Energy Metabolism; Female; Humans; Male; Mercaptopurine; Methotrexate; Obesity; Physical Exertion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Reference Values; Survivors; Vincristine; Weight Gain | 1998 |
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Constitution; Body Mass Index; Body Surface Area; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Leukocyte Count; Leukopenia; Methotrexate; Middle Aged; Obesity | 2001 |
Are medical oncologists biased in their treatment of the large woman with breast cancer?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Attitude of Health Personnel; Body Mass Index; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Medical Oncology; Methotrexate; Middle Aged; Obesity; Ontario; Practice Patterns, Physicians'; Prejudice; Retrospective Studies | 2001 |
Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Humans; Kidney Diseases; Leucovorin; Male; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioisotope Renography | 2002 |
Insulin and growth hormone secretion in a leukaemic girl with hypothalamic syndrome.
Topics: Arginine; Child; Female; Growth Hormone; Humans; Insulin; Insulin Secretion; Leukemia, Lymphoid; Methotrexate; Obesity; Triamcinolone; Vincristine | 1977 |
Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Aspartate Aminotransferases; Body Weight; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis | 1976 |
Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Aspartate Aminotransferases; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis | 1976 |
Endocrine profile in breast cancer patients receiving chemotherapy.
Topics: Adult; Age Factors; Amenorrhea; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Estrone; Female; Fluorouracil; Hormones; Humans; Luteinizing Hormone; Methotrexate; Middle Aged; Obesity; Prolactin | 1992 |
Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Humans; Incidence; Liver; Liver Cirrhosis; Liver Diseases; Methotrexate; Middle Aged; Obesity; Pulmonary Fibrosis | 1992 |
Disposition of high-dose methotrexate in an obese cancer patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Half-Life; Humans; Leucovorin; Methotrexate; Obesity; Osteosarcoma; Tibia; Vincristine | 1991 |
Psoriasis-liver-methotrexate interactions.
Topics: Administration, Oral; Adrenal Cortex Hormones; Age Factors; Alanine Transaminase; Alcohol Drinking; Alkaline Phosphatase; Aspartate Aminotransferases; Biopsy; Diabetes Complications; Female; Humans; Liver; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Sex Factors; Sulfobromophthalein; Time Factors | 1973 |
Liver biopsy in psoriasis.
Topics: Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Transaminases | 1970 |
Hepatotoxicity of methotrexate in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Diabetes Complications; Female; Follow-Up Studies; Humans; Liver; Liver Function Tests; Male; Methotrexate; Middle Aged; Obesity; Prospective Studies; Psoriasis; Retrospective Studies | 1971 |
[Complications in the central nervous system in acute leukemia in children. Clinical contribution].
Topics: Central Nervous System Diseases; Humans; Leukemia; Methotrexate; Neurologic Manifestations; Obesity | 1969 |